Two Sigma Investments, LP Fibrogen Inc Transaction History

Two Sigma Investments, LP

  • $42.3 Billion
  • Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Fibrogen Inc stock. As of the latest transaction made, Two Sigma Investments, LP holds 505,533 shares of FGEN stock, worth $176,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares
505,533
Previous 801,647 36.94%
Holding current value
$176,936
Previous $713,000 71.67%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$0.33 - $1.26 $97,717 - $373,103
-296,114 Reduced 36.94%
505,533 $202,000
Q2 2024

Aug 14, 2024
SELL
$0.89 - $2.36 $7,675 - $20,352
-8,624 Reduced 1.06%
801,647 $713,000
Q1 2024

May 15, 2024
SELL
$0.73 - $2.73 $942,438 - $3.52 Million
-1,291,012 Reduced 61.44%
810,271 $1.9 Million
Q4 2023

Feb 14, 2024
BUY
$0.38 - $0.91 $90,470 - $216,653
238,081 Added 12.78%
2,101,283 $1.87 Million
Q3 2023

Nov 14, 2023
BUY
$0.79 - $2.83 $389,610 - $1.4 Million
493,178 Added 36.0%
1,863,202 $1.6 Million
Q2 2023

Aug 14, 2023
BUY
$2.49 - $20.59 $1.09 Million - $9 Million
437,115 Added 46.86%
1,370,024 $3.7 Million
Q1 2023

May 15, 2023
BUY
$15.95 - $25.18 $5.88 Million - $9.28 Million
368,735 Added 65.36%
932,909 $17.4 Million
Q4 2022

Feb 14, 2023
BUY
$13.27 - $17.73 $1.55 Million - $2.07 Million
116,822 Added 26.11%
564,174 $9.04 Million
Q3 2022

Nov 14, 2022
SELL
$11.4 - $14.6 $1.52 Million - $1.95 Million
-133,617 Reduced 23.0%
447,352 $5.82 Million
Q2 2022

Aug 15, 2022
SELL
$7.94 - $12.96 $1.47 Million - $2.39 Million
-184,593 Reduced 24.11%
580,969 $6.14 Million
Q1 2022

May 16, 2022
SELL
$12.02 - $16.79 $3.17 Million - $4.43 Million
-263,628 Reduced 25.62%
765,562 $9.2 Million
Q4 2021

Feb 14, 2022
SELL
$9.93 - $15.39 $3.04 Million - $4.72 Million
-306,615 Reduced 22.95%
1,029,190 $14.5 Million
Q3 2021

Nov 15, 2021
BUY
$10.18 - $26.64 $11 Million - $28.9 Million
1,084,016 Added 430.53%
1,335,805 $13.7 Million
Q2 2021

Aug 16, 2021
BUY
$18.57 - $35.68 $2.08 Million - $3.99 Million
111,790 Added 79.85%
251,789 $6.71 Million
Q1 2021

May 17, 2021
BUY
$31.0 - $55.72 $3.05 Million - $5.48 Million
98,292 Added 235.67%
139,999 $4.86 Million
Q4 2020

Feb 16, 2021
SELL
$37.09 - $48.97 $5.28 Million - $6.97 Million
-142,264 Reduced 77.33%
41,707 $1.55 Million
Q3 2020

Nov 16, 2020
SELL
$40.47 - $45.5 $2.99 Million - $3.36 Million
-73,759 Reduced 28.62%
183,971 $7.57 Million
Q2 2020

Aug 14, 2020
BUY
$32.57 - $42.83 $7.02 Million - $9.23 Million
215,395 Added 508.79%
257,730 $10.4 Million
Q1 2020

May 15, 2020
SELL
$23.3 - $45.96 $1.74 Million - $3.43 Million
-74,610 Reduced 63.8%
42,335 $1.47 Million
Q4 2019

Feb 14, 2020
SELL
$34.58 - $48.06 $3.61 Million - $5.02 Million
-104,438 Reduced 47.18%
116,945 $5.02 Million
Q3 2019

Nov 14, 2019
BUY
$36.98 - $48.45 $6.38 Million - $8.36 Million
172,583 Added 353.65%
221,383 $8.19 Million
Q2 2019

Aug 14, 2019
SELL
$35.13 - $55.53 $633,393 - $1 Million
-18,030 Reduced 26.98%
48,800 $2.21 Million
Q1 2019

May 15, 2019
BUY
$42.83 - $59.91 $1.85 Million - $2.59 Million
43,162 Added 182.36%
66,830 $3.63 Million
Q4 2018

Feb 14, 2019
BUY
$37.97 - $60.16 $898,673 - $1.42 Million
23,668 New
23,668 $1.1 Million
Q3 2018

Nov 14, 2018
SELL
$56.3 - $67.25 $860,038 - $1.03 Million
-15,276 Closed
0 $0
Q2 2018

Aug 14, 2018
SELL
$44.9 - $64.95 $8.77 Million - $12.7 Million
-195,409 Closed
0 $0
Q1 2018

May 15, 2018
BUY
$45.35 - $61.65 $7.6 Million - $10.3 Million
167,586 Added 602.33%
195,409 $9.03 Million
Q4 2017

Feb 14, 2018
SELL
$41.95 - $60.1 $570,729 - $817,660
-13,605 Reduced 32.84%
27,823 $1.32 Million
Q3 2017

Nov 14, 2017
BUY
$33.4 - $53.9 $1.38 Million - $2.23 Million
41,428
41,428 $2.23 Million

Others Institutions Holding FGEN

# of Institutions
82
Shares Held
47.1M
Call Options Held
387K
Put Options Held
672K
View Full List

About FIBROGEN INC

FGEN Quotes by TradingView
  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $32.8M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email